J.M. DiPirro, M.B. Kristal / Brain Research 1014 (2004) 22-33
33
[75] G.C. Rossi, G.W. Pasternak, R.J. Bodnar, A and y synergy between
the periaqueductal gray and the rostro-ventral medulla, Brain Res. 665
(1994) 85-93.
[76] G.C. Rossi, W. Su, L. Levanthal, H. Su, G.W. Pasternak, Antisense
mapping DOR-1 in mice: further support for y receptor subtypes,
Brain Res. 753 (1997) 176 - 179.
[77] R.B. Rothman, J.W. Holaday, F. Porecca, Allosteric coupling
among opioid receptors: evidence for an opioid receptor complex,
in: A. Herz, H. Akil, E.J. Simon (Eds.), Handbook of Experimental
Pharmacology: Opioids, I vol. 104, Springer-Verlag, Berlin, 1993,
pp. 217 - 237.
[78] H.W. Sander, A.R. Gintzler, Spinal cord mediation of the opioid
analgesia of pregnancy, Brain Res. 408 (1987) 389 - 393.
[79] J.A. Schriefer, Diethylstilbesterol- and pregnancy-induced changes in
rat neurointermediate lobe oxytocin, arginine vasopressin, methionine
enkephalin and dynorphin, Neuroendocrinology 54 (1991) 185 - 191.
[80] S. Siegel, N.J. Castellan Jr., Nonparametric Statistics for the Behav-
ioral Sciences, McGraw-Hill, New York, 1988.
[81] A.S. Smith, N.M. Lee, Opioid receptor interactions: local and nonlo-
cal, symmetric and symmetric, physical and functional, Life Sci. 73
(2003) 1873 - 1893.
[82] D.J. Smith, J.M. Perrotti, T. Crisp, M.E.Y. Cabral, J.T. Long, J.M.
Scalzitti, The mu receptor is responsible for descending pain inhibi-
tion originating in the periaqueductal gray region of the rat, Eur. J.
Pharmacol. 156 (1988) 47-54.
[83] I. Sora, M. Funada, G.R. Uhl, The A-opioid receptor is necessary for
[d-Pen2,d-Pen5]enkephalin-induced analgesia, Eur. J. Pharmacol. 324
(1997) R1 -R2.
[84] I. Sora, N. Takahashi, M. Funada, H. Ujike, R.S. Revay, D.M.
Donovan, L.L. Miner, G.R. Uhl, Opiate receptor knockout mice
define A receptor roles in endogenous nociceptive responses and
morphine-induced analgesia, Proc. Natl. Acad. Sci. U. S. A. 94
(1997) 1544 - 1549.
[85] R.L. Spencer, V.J. Hruby, T.F. Burks, Body temperature response
profiles for selective mu, delta and kappa opioid agonists in
restrained and unrestrained rats, J. Pharmacol. Exp. Ther. 246
(1988) 92 - 101.
[86] A.E. Takemori, P.S. Portoghese, Evidence for the interaction of mor-
phine with kappa and delta opioid receptors to induce analgesia in h-
Funaltrexamine-treated mice, J. Pharmacol. Exp. Ther. 243 (1987)
91 -94.
[87] J.A. Tarapacki, A.C. Thompson, M.B. Kristal, Gastric vagotomy
blocks opioid analgesia enhancement produced by placenta ingestion,
Physiol. Behav. 52 (1992) 179 - 182.
[88] J.A. Tarapacki, M. Piech, M.B. Kristal, Ingestion of amniotic fluid by
postpartum rats enhances morphine analgesia without liability to ma-
ternal behavior, Physiol. Behav. 57 (1995) 209 - 212.
[89] A.C. Thompson, M.B. Kristal, Opioid stimulation in the ventral teg-
mental area stimulates maternal behavior in rats, Brain Res. 743
(1996) 184 - 201.
[90] A.C. Thompson, J.M. DiPirro, C.D. Dickerson, M.B. Kristal, Amni-
otic-fluid ingestion inhibits contralateral circling after unilateral mor-
phine injection into the ventral tegmental area, Abstr.-Soc. Neurosci.
17 (1991) 1539.
[91] L.L. Tseng, R. Tang, R. Stackman, A. Camara, J.M. Fujimoto, Brain-
stem sites differentially sensitive to beta-endorphin and morphine for
analgesia and release of met-enkephalin in anesthetized rats, J. Phar-
macol. Exp. Ther. 253 (1990) 930 - 937.
[92] P.F. Von Voigtlander, R.A. Lewis, Analgesic and mechanistic evalu-
ation of spiradoline, a potent kappa opioid, J. Pharmacol. Exp. Ther.
246 (1988) 259 - 262.
[93] P.F. Von Voigtlander, R.A. Lahti, J.H. Ludens, U-50,488: a selective
and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol.
Exp. Ther. 224 (1983) 7-12.
[94] H.Q. Wang, J.P. Kampine, L.F. Tseng, Antisense oligodeoxynucleo-
tides to delta-opioid receptor messenger RNA selectively blocks the
antinociception induced by intracerebroventricularly administered
delta-, but not mu-, epsilon-, or kappa-opioid receptor agonists in
the mouse, Neuroscience 7 (1996) 445 - 452.
[95] L.R. Wardlaw, A.G. Frantz, Brain beta-endorphin during pregnancy,
parturition and the postpartum period, Endocrinology 113 (1983)
1664 - 1668.
[96] L.R. Watkins, E.P. Wiertelak, S.F. Maier, Kappa opiate receptors
mediate tail-shock induced antinociception at spinal levels, Brain
Res. 582 (1992) 1-9.
[97] G. Woolfe, A.D. MacDonald, The evaluation of analgesic action of
pethidine hydrochloride (Demerol), J. Pharmacol. Exp. Ther. 80
(1944) 300 - 307.
[98] L. Xin, E.B. Geller, M.W. Adler, Body temperature and analgesic
effects of selective mu and kappa opioid receptors microdialyzed into
rat brain, J. Pharmacol. Exp. Ther. 281 (1997) 499 - 507.
[99] G.A. Young, N. Khazan, Differential tolerance and cross-tolerance to
repeated daily injections of mu and kappa agonists in the rat, Neuro-
pharmacology 23 (1984) 505 - 509.
More intriguing information
1. The name is absent2. WP 36 - Women's Preferences or Delineated Policies? The development or part-time work in the Netherlands, Germany and the United Kingdom
3. Problems of operationalizing the concept of a cost-of-living index
4. Do the Largest Firms Grow the Fastest? The Case of U.S. Dairies
5. Program Semantics and Classical Logic
6. ANTI-COMPETITIVE FINANCIAL CONTRACTING: THE DESIGN OF FINANCIAL CLAIMS.
7. On the Existence of the Moments of the Asymptotic Trace Statistic
8. The name is absent
9. Une nouvelle vision de l'économie (The knowledge society: a new approach of the economy)
10. The storage and use of newborn babies’ blood spot cards: a public consultation